Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danazol in severe telomeropathy (ANDROTELO)
NCT03710356Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2018
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of danazol in telomere biology disorder (TBD), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
danazol
03
Conditions
telomere biology disorder (TBD)
Beyond the preview
Go deeper on NCT03710356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710356.